{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:50:32Z","timestamp":1791355832887,"version":"4.3.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"\n Background<\/jats:title>\n Residual neuromuscular blockade after general anaesthesia is a cause of postoperative pulmonary complications and delayed recovery. Sugammadex, a relaxant-binding agent, is a fast-acting antidote for aminosteroid neuromuscular block which works through encapsulation, in contrast to acetylcholinesterase inhibitors like neostigmine. This study evaluated the effectiveness, postoperative recovery and complications associated with sugammadex versus conventional anticholinesterase reversal drugs in adult surgical patients.<\/jats:p>\n <\/jats:sec>\n \n Method<\/jats:title>\n This systematic review and meta-analysis was done based on the PRISMA 2020 statement. Databases like PubMed\/MEDLINE and Scopus were used to search the literature from January 2000 to December 2025. Studies comparing the use of sugammadex to anticholinesterase agents in adult surgical patients were included, both randomised and non-randomised. Two independent reviewers screened, extracted data and assessed the risk of bias. Analyses were carried out in RevMan 5.3 software using random-effect models; the odds ratio (OR) for dichotomous outcomes and the mean difference (MD) for continuous outcomes were used with 95% confidence intervals (CI). Evidence certainty was assessed using the GRADE approach.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Total of ten studies (\n n<\/jats:italic>\n \u202f=\u202f4,082) were included; 5 randomised control trials and 5 observational studies. There was no statistically significant reduction in postoperative pulmonary complications with sugammadex compared to anticholinesterase (3 studies,\n n<\/jats:italic>\n \u202f=\u202f688; OR 0.75, 95% CI 0.47\u20131.20;\n p<\/jats:italic>\n \u202f=\u202f0.23; I\n 2<\/jats:sup>\n =\u202f77%). There was faster recovery of neuromuscular function with sugammadex, however, there was very high heterogeneity among the studies and the pooled estimate cannot be interpreted as one single effect size (2 studies; I\n 2<\/jats:sup>\n =\u202f100%). Recovery time after surgery was reduced (3 studies,\n n<\/jats:italic>\n \u202f=\u202f260; MD -6.66\u202fmin, 95% CI \u22126.96 to \u22126.35;\n p<\/jats:italic>\n \u202f&lt;\u202f0.00001; I\n 2<\/jats:sup>\n =\u202f87%) and time to first bowel movement was also earlier (2 studies,\n n<\/jats:italic>\n \u202f=\u202f559; MD \u221213.81\u202fh, 95% CI -19.16 to \u22128.45;\n p<\/jats:italic>\n \u202f&lt;\u202f0.00001; I\n 2<\/jats:sup>\n =\u202f0%). There were no statistically significant differences for PACU stay (MD 1.55\u202fmin, 95% CI \u22121.60 to 4.69), readmission rate (OR 0.93, 95% CI 0.62\u20131.39) and postoperative nausea\/vomiting (OR 0.86, 95% CI 0.48\u20131.56).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Faster neuromuscular recovery, shorter recovery time after surgery and early return of bowel function was associated with the use of sugammadex rather than the anticholinesterase agents. There were no differences found for postoperative pulmonary complications, PACU stay, readmission rate or nausea and vomiting. These results are based on small number of clinically heterogeneous studies, in which only 2\u20134 studies were used in pooling and thus should be considered as preliminary results.<\/jats:p>\n <\/jats:sec>\n \n Systematic review registered<\/jats:title>\n CRD420261364292.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fmed.2026.1891778","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:59:40Z","timestamp":1791352780000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Sugammadex versus anticholinesterase reversal of neuromuscular blockade in adult surgical patients: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Faris Suleiman Saleh","family":"Aldobekhi","sequence":"first","affiliation":[{"name":"Department of Surgical Subspecialities, College of Medicine, Majmaah University","place":["Al Majmaah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Fahad","family":"Aldhahi","sequence":"additional","affiliation":[{"name":"Department of Surgical Subspecialities, College of Medicine, Majmaah University","place":["Al Majmaah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad Awadh","family":"Almalki","sequence":"additional","affiliation":[{"name":"King Salman Armed Forces Hospital","place":["Tabuk, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Aljahdali","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, King Abdulaziz Medical City, Ministry of the National Guard Health Affairs","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Alshamrani","sequence":"additional","affiliation":[{"name":"SEHA Virtual Hospital","place":["Makkah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somaia Sameer","family":"Akbar","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, King Abdulaziz Medical City, Ministry of the National Guard Health Affairs","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan Awwadh","family":"Almalki","sequence":"additional","affiliation":[{"name":"King Abdulaziz Medical City","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"7201","DOI":"10.3390\/jcm11237201","article-title":"Low intra-abdominal pressure with complete neuromuscular blockage reduces post-operative complications in major laparoscopic urologic surgery: a before-after study","volume":"11","author":"Brusasco","year":"2022","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1007\/s12630-019-01419-3","article-title":"Effects of neuromuscular block reversal with Sugammadex versus neostigmine on postoperative respiratory outcomes after major abdominal surgery: a randomized-controlled trial","volume":"66","author":"Alday","year":"2019","journal-title":"Can J Anaesth"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1093\/bja\/53.12.1315","article-title":"Comparison of atropine and Glycopyrrolate in a mixture with Pyridostigmine for the antagonism of neuromuscular block","volume":"53","author":"Mirakhur","year":"1981","journal-title":"Br J Anaesth"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s40265-016-0604-1","article-title":"Sugammadex: a review of neuromuscular blockade reversal","volume":"76","author":"Keating","year":"2016","journal-title":"Drugs"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"CD012763","DOI":"10.1002\/14651858.CD012763","article-title":"Efficacy and safety of Sugammadex versus neostigmine in reversing neuromuscular blockade in adults","volume":"8","author":"Hristovska","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"919","DOI":"10.2165\/00003495-200969070-00008","article-title":"Sugammadex: a review of its use in anaesthetic practice","volume":"69","author":"Yang","year":"2009","journal-title":"Drugs"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/ajhp\/56.S4","article-title":"Clinical pharmacology of neuromuscular blocking agents","volume":"56","author":"Fisher","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"i53","DOI":"10.1093\/bja\/aex318","article-title":"Reversal of residual neuromuscular block: complications associated with perioperative management of muscle relaxation","volume":"119","author":"Hunter","year":"2017","journal-title":"Br J Anaesth"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.2174\/1381612825666190704101145","article-title":"Sugammadex for reversal of neuromuscular blockade: uses and limitations","volume":"25","author":"Hawkins","year":"2019","journal-title":"Curr Pharm Des"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1213\/ANE.0000000000007013","article-title":"Impact of sugammadex versus neostigmine reversal on postoperative recovery time in patients with obstructive sleep apnea undergoing bariatric surgery: a double-blind randomized controlled trial","volume":"140","author":"Ajetunmobi","year":"2025","journal-title":"Anesth Analg"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/jcm10050938","article-title":"Quality of recovery after laparoscopic cholecystectomy following neuromuscular blockade reversal with neostigmine or sugammadex: a prospective randomized controlled trial","volume":"10","author":"Han","year":"2021","journal-title":"J Clin Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.bja.2021.04.026","article-title":"Reversal of residual neuromuscular block with neostigmine or sugammadex and postoperative pulmonary complications: a prospective, randomised, double-blind trial in high-risk older patients","volume":"127","author":"Ledowski","year":"2021","journal-title":"Br J Anaesth"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3325\/cmj.2021.62.606","article-title":"Comparison of recovery after sugammadex or neostigmine reversal of rocuronium in geriatric patients undergoing spine surgery: a randomized controlled trial","volume":"62","author":"Mraovic","year":"2021","journal-title":"Croat Med J"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1053\/j.jvca.2022.03.033","article-title":"Sugammadex versus neostigmine for neuromuscular block reversal and postoperative pulmonary complications in patients undergoing resection of lung cancer","volume":"36","author":"Yu","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/jcm8010097","article-title":"Thirty-day postoperative outcomes following sugammadex use in colorectal surgery patients: retrospective study","volume":"8","author":"Chae","year":"2019","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/1060028020929061","article-title":"Effects on postoperative gastrointestinal motility after neuromuscular blockade reversal with sugammadex versus neostigmine\/glycopyrrolate in colorectal surgery patients","volume":"54","author":"Hunt","year":"2020","journal-title":"Ann Pharmacother"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.22514\/sv.2020.16.0116","article-title":"Post-operative respiratory outcomes associated with the use of sugammadex in laparoscopic colorectal cancer surgery: a retrospective propensity score-matched cohort study","volume":"17","author":"Oh","year":"2021","journal-title":"Signa Vitae"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.23736\/S0375-9393.20.14589-9","article-title":"Neuromuscular blockade management and postoperative outcomes in enhanced recovery colorectal surgery: secondary analysis of PoWer trial","volume":"87","author":"Serrano","year":"2021","journal-title":"Minerva Anestesiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10151-022-02695-w","article-title":"Effect of neuromuscular reversal with neostigmine\/glycopyrrolate versus sugammadex on postoperative ileus following colorectal surgery","volume":"27","author":"Traeger","year":"2023","journal-title":"Tech Coloproctol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.17305\/bb.2025.12689","article-title":"Sugammadex vs neostigmine in post-anesthesia recovery: a systematic review and meta-analysis","volume":"26","author":"Zhu","year":"2025","journal-title":"Biomolecules Biomed"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s12871-025-03334-1","article-title":"The effect of sugammadex on postoperative urinary retention and recovery characteristics: a systematic review and meta-analysis","volume":"25","author":"Ni","year":"2025","journal-title":"BMC Anesthesiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/aer.aer_79_21","article-title":"Efficacy and safety of Sugammadex versus neostigmine in reversing neuromuscular blockade in morbidly obese adult patients: a systematic review and Meta-analysis","volume":"15","author":"Subramani","year":"2021","journal-title":"Anesth Essays Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.35975\/apic.v29i5.2869","article-title":"Sugammadex versus neostigmine for neuromuscular blockade reversal after surgery in pediatric patients: a systematic review and meta-analysis of randomized clinical trials","volume":"29","author":"Waren","year":"2025","journal-title":"Anaesth Pain Intensive Care"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"100531","DOI":"10.1016\/j.bjao.2026.100531","article-title":"Sugammadex, neostigmine, and postoperative pulmonary complications: protocol of the SNaPP multicentre randomised controlled trial","volume":"17","author":"Leslie","year":"2026","journal-title":"BJA Open"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1891778\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:59:41Z","timestamp":1791352781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1891778\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":25,"alternative-id":["10.3389\/fmed.2026.1891778"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1891778","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"1891778"}}